The Outcome of BA.5 Omicron in Transplant Cases: A Retrospective Single-center Study in Jeddah Saudi Arabia
Mona Bahasan,
No information about this author
Ghaliah A. Alhaqas,
No information about this author
Salma Ayman Almosallam
No information about this author
et al.
Dr Sulaiman Al Habib Medical Journal,
Journal Year:
2025,
Volume and Issue:
7(1), P. 22 - 29
Published: Jan. 1, 2025
Abstract
Introduction:
The
global
incidence
of
coronavirus
disease
2019
(COVID-19)
has
increased
significantly
due
to
the
Omicron
wave.
interaction
between
host
factors,
including
immune
status
and
vaccination
history,
along
with
circulating
SARS-CoV-2
variant,
collectively
influences
clinical
outcomes
following
exposure
COVID-19.
Material
Methods:
This
retrospective
study
examined
patients
infected
COVID-19
during
BA.5
wave
at
King
Faisal
Specialist
Hospital
Research
Center
in
Jeddah,
Saudi
Arabia.
Results:
A
total
25
were
included
study,
comprising
12
(48%)
males
13
(52%)
females.
Despite
most
having
multiple
underlying
chronic
medical
conditions
a
mean
age
48
years,
isolated
home.
Three
(12%)
asymptomatic,
17
(68%)
experienced
mild
symptoms,
1
(4%)
developed
pneumonia
not
requiring
oxygen,
2
(8%)
required
low-flow
invasive
ventilation.
22
(88%)
had
received
vaccinations,
6
(24%)
receiving
doses,
3
4
doses.
Mortality
was
reported
patients;
however,
no
deaths
observed
among
renal
transplant
recipient
variant.
Conclusion:
Our
findings
suggest
that
who
underwent
transplantation
variant
lower
mortality
rates
shorter
ICU
stays
compared
those
BA.1
or
BA.2
outcome
may
be
attributed
higher
proportion
three
doses
vaccine.
Language: Английский
SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India
Mansi Patel,
No information about this author
Uzma Shamim,
No information about this author
Umang Umang
No information about this author
et al.
PLoS neglected tropical diseases,
Journal Year:
2025,
Volume and Issue:
19(3), P. e0012918 - e0012918
Published: March 10, 2025
Background
COVID-19
pandemic
had
unprecedented
global
impact
on
health
and
society,
highlighting
the
need
for
a
detailed
understanding
of
SARS-CoV-2
evolution
in
response
to
host
environmental
factors.
This
study
investigates
via
mutation
dynamics,
focusing
distinct
age
cohorts,
geographical
location,
vaccination
status
within
Indian
population,
one
nations
most
affected
by
COVID-19.
Methodology
Comprehensive
dataset,
across
diverse
time
points
during
Alpha,
Delta,
Omicron
variant
waves,
captured
essential
phases
pandemic’s
footprint
India.
By
leveraging
genomic
data
from
Global
Initiative
Sharing
Avian
Influenza
Data
(GISAID),
we
examined
substitution
landscape
three
demographic
segments:
children
(1–17
years),
working-age
adults
(18–64
elderly
individuals
(65+
years).
A
balanced
dataset
69,975
samples
was
used
study,
comprising
23,325
each
group.
design
ensured
high
statistical
power,
as
confirmed
power
analysis.
We
employed
bioinformatics
analyses,
explore
genetic
diversity
patterns
frequencies
groups.
Principal
findings
The
group
exhibited
notably
frequency
unique
substitutions,
suggesting
that
immune
pressures
highly
interactive
populations
may
accelerate
viral
adaptation.
Geographic
analysis
emphasizes
notable
regional
variation
rates,
potentially
driven
population
density
local
transmission
while
regions
with
more
homogeneous
strain
circulation
show
relatively
lower
rates.
also
revealed
significant
surge
substitutions
all
groups
period,
rates
remaining
elevated
even
after
widespread
vaccination,
compared
pre-vaccination
levels.
trend
supports
virus’s
adaptive
heightened
observed
through
increased
prevalence
important
genome
like
ORF1ab
Spike,
contributing
escape
transmissibility.
Conclusion
Our
affirm
importance
continuous
surveillance
evolution,
particularly
countries
research
provides
insights
anticipating
future
outbreaks
refining
preparedness
strategies,
thus
enhancing
our
capacity
proactive
responses.
Language: Английский
Comparative Atlas of SARS-CoV-2 Substitution Mutations: A Focus on Iranian Strains Amidst Global Trends
Viruses,
Journal Year:
2024,
Volume and Issue:
16(8), P. 1331 - 1331
Published: Aug. 20, 2024
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
a
new
emerging
that
caused
disease
2019
(COVID-19).
Whole-genome
tracking
of
SARS-CoV-2
enhanced
our
understanding
the
mechanism
disease,
control,
and
prevention
COVID-19.
Language: Английский